Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
24-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #90056
advertisement
Qin Y
21
Showing records 1 to 21 |
Display all abstracts from
Qin Y
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Zhang Y
BMC Ophthalmology
2024; 24: 108
118268
Identification of potential core genes in pseudoexfoliation using bioinformatics analysis and retrospective analysis of 84 patients with this disease
Liu X; Qin Y
International Ophthalmology
2024; 44: 161
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Lai C
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lai Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118268
Identification of potential core genes in pseudoexfoliation using bioinformatics analysis and retrospective analysis of 84 patients with this disease
Wei B
International Ophthalmology
2024; 44: 161
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Zhao S
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118268
Identification of potential core genes in pseudoexfoliation using bioinformatics analysis and retrospective analysis of 84 patients with this disease
Ding L
International Ophthalmology
2024; 44: 161
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Li L
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lin J; Huang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Luo X
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Chen Y
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Chen Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Niu Y
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Hu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Qin Y
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cheng Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118287
Comparison of bleb morphologies between phacoemulsification combined with Ex-PRESS mini shunt implantation, phacotrabeculectomy and trabeculectomy alone: a two-year retrospective in vivo confocal microscopy study
Zhang H
BMC Ophthalmology
2024; 24: 108
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Jiang L; Cui L; Zhong H; Li M; Wei Y; Xu F
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept